Skip to NavigationSkip to content

News

MSD has unveiled new Phase 3 data on its blockbuster anti-PD-1 cancer therapy Keytruda (pembrolizumab) as part of a combination, this time with...
Check out this week's top 10 stories at Pharmafile.com now!
The US Food and Drug Administration (FDA) is offering a proposal to the International Council on Harmonisation (ICH) aimed at harmonising the...
Eli Lilly and patients with breast cancer patients in the UK have been dealt a blow as NICE confirmed that it has decided not to recommend the...
The international non-governmental organisation (NGO) Médecins Sans Frontières (MSF) has warned that antibiotic resistant infections are a “...
British MPs questioned the first robot to ever attend a UK parliamentary meeting this month, after a robot called Pepper offered insight into the...
GlaxoSmithKline’s workforce on President’s Island in Memphis, US, is set to see the loss of 99 employees, as revealed in a WARN notice filed with...
Novartis will shell out $2.1 billion to acquire cancer drug developer Endocyte in a move to leverage the company’s technology to investigate...
The British government has extended the expiry date on epinephrine pens amid a shortage in the UK.
US pharma giant Pfizer is offering early retirement to American workers ahead of layoffs scheduled for next year.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches